Table 2.
Calculated fracture risks
FRAX fracture risk from clinical risk factors including ADT as secondary osteoporosis: |
||
Median % hip fracture risk (range) | 3.1 | (0.2–26) |
No. 3% or greater 10-yr hip fracture risk (%) | 186 | (51.2) |
Median % MOF risk (range) | 12 | (2.2–33) |
No. 20% or greater 10-y MOF risk (%) | 37 | (10.2) |
FRAX fracture risk from clinical risk factors excluding ADT as secondary osteoporosis: |
||
Median % hip fracture risk (range) | 1.8 | (0.1–16) |
No. 3% or greater 10-yr hip fracture risk (%) | 119 | (32.8) |
Median % MOF risk (range) | 8.4 | (1.6–25) |
No. 20% or greater 10-yr MOF risk (%) | 4 | (1.1) |
FRAX fracture risk calculated using measured femoral neck BMD (in 93 pts): |
||
Median T score (range) | −1.0 | (−3.4–2.2) |
Median gm/cc BMD (range) | 0.81 | (0.47–1.23) |
Median % hip fracture risk with DXA (range) | 0.9 | (0–15) |
Median % hip fracture risk without DXA (range) | 2.4 | (0.2–26) |
Median % MOF risk with DXA (range) | 7.0 | (2.5–25) |
Median % MOF risk without DXA (range) | 11 | (3.0–33) |
No. 3% or greater 10-yr hip fracture risk + T score less than −1 (%) |
14 | (15) |
No. 3% or greater 10-yr hip fracture risk without DXA (%) |
41 | (44.1) |
No. T score −2.5 or less (%) | 6 | (6.5) |